| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Molecular and Cell Biology [Y. C., C. M., R. Mo., X. Z., J. D., D. Y., R. Me., F. C., R. S.] and Applied Bioinformatics [M. M., B. B.], Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139; Gynecologic Surgery, Mayo Clinic, Rochester, Minnesota 55905 [B. S. G.]; and Department of Obstetrics, Gynecology and Reproductive Sciences and Cancer Research Institute, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143-0128 [K. S-M.]
The Pap test has effectively reduced the incidence and mortality of cervical cancer. However, because of the morphological basis of this test, sensitivity and specificity are less than ideal, a situation that complicates the clinical management of women diagnosed with low-grade cervical abnormalities. In an attempt to understand the molecular basis of cervical tumorigenesis and to discover molecular markers for accurate cervical cancer screening, we used cDNA microarrays containing >30,000 Unigene clones to examine the gene expression patterns of 34 cervical tissues from different clinically defined stages. It was found that global gene expression patterns separated normal cervical tissues and low-grade squamous intraepithelial lesions from cervical cancers and most of the high-grade squamous intraepithelial lesions (HSILs). Among the top 62 genes/(expressed sequence tags) that were overexpressed in tumors and HSIL tissues, 35 were confirmed using in situ hybridization on cervical tissue micorarrays. Many of these genes were overexpressed in high-grade dysplastic and malignant cervical epithelium or in stroma adjacent to the diseased tissues, with cellular proliferation and extracellular matrix-associated genes being the most common. In general, the extent of gene overexpression increased as the lesions progressed from low-grade squamous intraepithelial lesions to HSILs and finally to cancer. It is hoped that with additional development, some of these markers will improve the interpretation of cervical screening tests and provide useful information for patient management decisions.
This article has been cited by other articles:
![]() |
P Conesa-Zamora, A Domenech-Peris, S Ortiz-Reina, F J Orantes-Casado, J Acosta-Ortega, J Garcia-Solano, and M Perez-Guillermo Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix J. Clin. Pathol., February 1, 2009; 62(2): 159 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shivapurkar, V. Stastny, N. Okumura, L. Girard, Y. Xie, C. Prinsen, F. B. Thunnissen, I. I. Wistuba, B. Czerniak, E. Frenkel, et al. Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene Cancer Res., September 15, 2008; 68(18): 7448 - 7456. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhai, R. Kuick, B. Nan, I. Ota, S. J. Weiss, C. L. Trimble, E. R. Fearon, and K. R. Cho Gene Expression Analysis of Preinvasive and Invasive Cervical Squamous Cell Carcinomas Identifies HOXC10 as a Key Mediator of Invasion Cancer Res., November 1, 2007; 67(21): 10163 - 10172. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Wang, Z. Zhang, H.-C. Wang, J.-L. Cai, Q.-W. Xu, M.-Q. Li, Y.-C. Chen, X.-P. Qian, T.-J. Lu, L.-Z. Yu, et al. Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder Carcinoma. Clin. Cancer Res., August 15, 2006; 12(16): 4851 - 4858. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Wright Response to "Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics", by Dannecker et al. (Ann Oncol 2004; 15: 863-869) and "Histopathological validation of the sentinel node concept in cervical cancer", by Barranger et al. (Ann Oncol 2004; 15: 870-874): DNA microarrays will be instrumental in the future diagnosis of cervical dysplasia and neoplasia Ann. Onc., April 1, 2005; 16(4): 675 - 676. [Full Text] [PDF] |
||||
![]() |
B. Akgul, R. Garcia-Escudero, L. Ghali, H. J. Pfister, P. G. Fuchs, H. Navsaria, and A. Storey The E7 Protein of Cutaneous Human Papillomavirus Type 8 Causes Invasion of Human Keratinocytes into the Dermis in Organotypic Cultures of Skin Cancer Res., March 15, 2005; 65(6): 2216 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Sgarlato, C. L. Eastman, and H. H. Sussman Panel of Genes Transcriptionally Up-regulated in Squamous Cell Carcinoma of the Cervix Identified by Representational Difference Analysis, Confirmed by Macroarray, and Validated by Real-Time Quantitative Reverse Transcription-PCR Clin. Chem., January 1, 2005; 51(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Maruya, H.-W. Kim, R. S. Weber, J. J. Lee, M. Kies, M. A. Luna, J. G. Batsakis, and A. K. El-Naggar Gene Expression Screening of Salivary Gland Neoplasms: Molecular Markers of Potential Histogenetic and Clinical Significance J. Mol. Diagn., August 1, 2004; 6(3): 180 - 190. [Abstract] [Full Text] |
||||
![]() |
F. Thierry, M. A. Benotmane, C. Demeret, M. Mori, S. Teissier, and C. Desaintes A Genomic Approach Reveals a Novel Mitotic Pathway in Papillomavirus Carcinogenesis Cancer Res., February 1, 2004; 64(3): 895 - 903. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |